Home haemodialysis in Ireland

Kennedy, Claire; Connaughton, Dervla M.; Murray, Susan; Ormond, John K.; Butler, Aine; Phelan, Elizabeth A.; Young, Joseph C.; Durack, L; Flavin, J; O’Grady, Michael J.; O’Kelly, Patrick; Lavin, Peter; Leavey, Sean F.; Lappin, David; Giblin, Louise; Casserly, Liam F.; Plant, W.D.; Conlon, Peter J.

doi:10.1093/qjmed/hcx249

Cited by 5 publications

(9 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The number of working years lost up to the age of 66 years was estimated, based on expected working years left by age group and the predicted number of deaths broken down by age group. The average annual industrial earnings for Ireland, 24 was then applied to estimate the productivity losses due to premature mortality. As per methodological guidance, all future earnings were discounted to present values at a 4% discount rate, as is recommended for Ireland.…”

Section: Indirect Costsmentioning

confidence: 99%

“…End-stage renal disease €46,514 Assumed that 54% 22 of people with End-stage renal disease had kidney transplantation (€30,191) 23 and 46% 22 were on haemodialysis (€65,676). 24 The estimated mean cost of a centre-based haemodialysis session was €421, 24 conducted with a schedule of three four-hour sessions every week. 24 The minimum inpatient cost due to kidney transplantation was obtained from diagnosis related group (DRG) admission in Ireland and was provided by HSE'S Healthcare Pricing Office.…”

Section: Macroalbuminuria €50mentioning

confidence: 99%

“…24 The estimated mean cost of a centre-based haemodialysis session was €421, 24 conducted with a schedule of three four-hour sessions every week. 24 The minimum inpatient cost due to kidney transplantation was obtained from diagnosis related group (DRG) admission in Ireland and was provided by HSE'S Healthcare Pricing Office. 23 These unit costs were converted to 2018 prices using the consumer price index for medical component.…”

Section: Macroalbuminuria €50mentioning

confidence: 99%

See 2 more Smart Citations

Estimating the cost of type 1 diabetes in Ireland

et al. 2022

View full text Add to dashboard Cite

Background: Type 1 diabetes is a chronic disease, which given its existing and projected prevalence, is likely to pose a significant economic burden, both in terms of directs costs to the healthcare system and indirect costs to society. We aimed to estimate the economic burden of type 1 diabetes in Ireland, which at present, is unknown. Methods:A cost of illness study was undertaken to estimate the cost of type 1 diabetes in Ireland for 2018. Data for prevalence, morbidity, mortality, healthcare resource use, absenteeism, and unit costs were obtained from national, and where necessary, international sources. Direct healthcare costs were estimated for primary care, outpatient, emergency and inpatient care, for associated complications, structured education programmes, insulin and related care. Additionally, indirect costs from lost earnings due to premature death and employee absenteeism were estimated.Results: Type 1 diabetes was estimated to cost €129 million in Ireland in 2018, with direct healthcare costs accounting for €81.5 million or 63% and indirect costs for €47.5 million or 37% of the total. On average, this amounted to €3994 per patient in direct healthcare costs and €2326 per patient in indirect costs. Conclusion:Type 1 diabetes is a leading public health problem. Our study is the first to assess the economic burden of type 1 diabetes in Ireland, and our results should be informative to policymakers tasked with prioritising healthcare and research funding resource allocation.

show abstract

Section: Indirect Costsmentioning

confidence: 99%

Section: Macroalbuminuria €50mentioning

confidence: 99%

Section: Macroalbuminuria €50mentioning

confidence: 99%

See 1 more Smart Citation

Estimating the cost of type 1 diabetes in Ireland

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Studies have shown that home healthcare has promising effects on cost, quality, and offers more flexibility to patients. For example, some studies 2–5 suggest that the cost of HHD is lower than the in‐center hemodialysis (ICHD). Besides, HHD offers a better health‐related quality of life, 4,6–11 and a low hospitalization rate 12 .…”

Section: Introductionmentioning

confidence: 99%

“…For example, some studies 2–5 suggest that the cost of HHD is lower than the in‐center hemodialysis (ICHD). Besides, HHD offers a better health‐related quality of life, 4,6–11 and a low hospitalization rate 12 . Furthermore, studies 13–15 indicate that HHD offers higher survival rates than the ICHD especially in the case of daily frequent and nocturnal hemodialysis.…”

Section: Introductionmentioning

confidence: 99%

Exploring stakeholders and their requirements in the process of home hemodialysis: A literature review

Khan

Pintelon

Martin

et al. 2021

Seminars in Dialysis

View full text Add to dashboard Cite

Providing home hemodialysis (HHD) therapy is a complex process that not only requires the use of a complex technology but also involves a diverse group of stakeholders, and each stakeholder has their requirements and may not share a common interest. Bringing them together will require the alignment of their interests. A process management perspective can help to accomplish the alignment of their interests. To align their interests, it is crucial to identify interest groups and understand their interests. The main objective of this paper is to identify the stakeholders and represents their interests as a list of requirements in the HHD process. An extensive literature review has been carried out and PubMed was used for literature extraction. In total, 1848 articles were retrieved of which 80 have fulfilled the inclusion criteria. A large array of actors is identified and their interests/requirements at different stages of the HHD process are represented in the form of a list. They have both common and conflicting requirements in the HHD process. If these requirements are aligned and balanced, a stakeholder's driven treatment process will be developed and a real improvement will be achieved in the treatment process.

show abstract

Nephrology in Ireland

Plant

2021

Nephrology Worldwide

View full text Add to dashboard Cite

Home haemodialysis in Ireland

Cited by 5 publications

References 17 publications

Estimating the cost of type 1 diabetes in Ireland

Estimating the cost of type 1 diabetes in Ireland

Exploring stakeholders and their requirements in the process of home hemodialysis: A literature review

Nephrology in Ireland

Contact Info

Product

Resources

About